Mayra

Dienogest/Ethinylestradiol, the active ingredient in Mayra, is a combined oral contraceptive presented as an oral tablet for oral use. It is indicated for prevention of pregnancy and treatment of menstrual disorders in women of reproductive age.

GNH USA supplies Mayra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mayra, a combined oral contraceptive, acts on the hormonal regulation of the menstrual cycle.

- Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed. - Treatment of menstrual disorders: helps regulate cycle length and reduce abnormal uterine bleeding. - Management of dysmenorrhea: alleviates painful menstrual cramps through hormonal stabilization. - Regulation of irregular cycles: promotes predictable bleeding patterns.

Mayra may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Headache - Breast tenderness - Spotting or irregular bleeding - Weight gain - Mood changes

Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Myocardial infarction - Severe allergic reaction (anaphylaxis) - Hepatic tumor (rare)

Before prescribing Mayra, clinicians should consider several safety precautions.

- Pregnancy: contraindicated; avoid use during pregnancy. - Smoking: women over 35 who smoke should not use this product. - Thromboembolic history: avoid in patients with past clotting disorders. - Hypertension: not recommended for uncontrolled high blood pressure. - Liver disease: use with caution in hepatic impairment. - Store at room temperature: keep in original packaging, protect from moisture and light.

Mayra can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy. - Rifampicin and other strong inducers: may lower hormone levels, increasing risk of pregnancy. - St. John’s wort: may decrease effectiveness of hormonal contraception.

Moderate Interactions (Monitor Closely): - Tetracycline antibiotics: may slightly reduce contraceptive effectiveness. - Antifungal ketoconazole: may increase hormone concentrations, raising side‑effect risk. - SSRIs (e.g., fluoxetine): may increase incidence of mood‑related side effects.